INC Research and Kendle unite
We're pleased to announce that INC Research has successfully acquired Kendle, creating a top-tier global CRO employing approximately 5,000 associates with experience spanning more than 100 countries across six continents. Ever committed to the successful execution and delivery of our customers' projects, our enhanced scale, expanded therapeutic expertise and new levels of operational excellence have strengthened our ability to deliver clinical trials of all sizes across the entire drug development spectrum.
Big things are happening at INC Research - visit the INC Research website to learn how we can help you think big, too.
Our highest priority remains the successful delivery of your project.
Visit INC Research today to explore our enhanced capabilities.
Volunteer participation in clinical studies remains essential to the successful development of better medicines.
A letter to our investigators
Register for INC Research's investigator database